Drug Shortage Report for MINT-OLANZAPINE ODT

Last updated on 2021-01-16 History
Report ID 108298
Drug Identification Number 02436973
Brand name MINT-OLANZAPINE ODT
Common or Proper name Olanzapine
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30 count Blisters
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-03-09
Estimated end date
Actual end date 2021-01-15
Shortage status Resolved
Updated date 2021-01-16
Company comments
Health Canada comments
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-16 English Compare
v5 2021-01-15 French Compare
v4 2021-01-15 English Compare
v3 2020-03-10 English Compare
v2 2020-03-09 French Compare
v1 2020-03-09 English Compare